Bryan Davies, PhD
Bryan completed his BSc in Biochemistry at McMaster University, PhD in Molecular Biology at MIT, and postdoctoral fellowship in infectious diseases at Harvard Medical School. He is an Associate Professor in the Departments of Molecular Biosciences and Medical Education. His research interests include antimicrobial discovery and development, bacterial pathogenesis, and microbe engineering.
Jennifer Parker, MSc
Jennifer completed her MSc in Environmental Health at the University of Washington. She has conducted research in diverse disciplines including environmental microbiology, plant pathology, and public health microbiology. Her current work is focused on discovering novel naturally-occurring antimicrobial peptides (microcins), elucidating their role in modulating the host microbiome, and engineering bacterial delivery systems to provide microcin-based therapeutics.
Renee Fleeman, PhD
Renee earned her PhD from the University of South Florida where she worked discovering novel small molecule antimicrobials. Her current work focuses on obtaining a better understanding of the innate immune system evasion strategies used by K. pneumoniae and using these interactions as targets for adjunctive therapeutics.
Orhi Esarte Palomero, PhD
Orhi earned his PhD at the University of Texas in inorganic chemistry. His research interests are in discovery and development of the functional (bio)materials and molecules.
Justin Randall, PhD
Justin earned his PhD at the University of Michigan studying bacterial DNA repair. He joined the Davies lab to pursue more translation research and is now developing peptide therapeutics targeting Vibrio cholerae.
Jeff Cole, PhD
Jeff earned his PhD from East Carolina University where he worked on developing bioinformatics and deep learning implementations to identify and characterize the molecular evolution of venom proteins in wandering spiders. He is now be using deep learning techniques to characterize and design antimicrobial peptides and proteins.
Xun received her BSc in biology from Tsinghua University in Beijing, China. Since joining Davies lab, she developed an interest in using microbiology to pave a way towards drug development. She studied how A. baumannii survive on dry surfaces for extended periods and spread within hospitals. Her current focus is on screening and engineering of novel antimicrobials.
Greg received his BSc in Biology with emphasis on microbiology at the University of Texas at Austin. His previous work studied the mechanism of action of the antimicrobial benzalkonium chloride. His graduate work focuses on bacterial pathogen strategies for host colonization and species specific biologic approaches to addressing pathogen colonization and infection.
Sun-Young Kim is from South Korea and majored in microbiology. He is interested in manipulating bacteria to make human lives better. Currently, he is engineering bacteria to secrete peptides as tools for delivery and biotechnology.
Dr. Ashley Tucker – Scientist, Anexigen Inc
Dr. Andy Goodrich – Scientist, Anexigen Inc
Alex Crofts – Postdoctoral fellow, Southwestern Medical Center
Dr. Joe Boll – Assistant Professor, University of Texas Arlington
Aaron Conrado – Public Policy, Washington DC
Misha Kazi – Graduate student, University of Texas Arlington
Cody Cole – Graduate student University of Chicago
Dr. Donna Jones – visiting Professor
Nora Burdis – internal medicine resident, John Hopkins
Santos Acosta – Medical school
Ashley Cunningham – Graduate student, Northwestern
Dr. Charles Gomes – Scientist, Thermo Scientific
Cory DuPai – Scientist, Leidos